NaevusBenignICD-10 D22.x

Common acquired naevi (junctional / compound / intradermal)

Common melanocytic naevus ยท ordinary naevus ยท banal naevus ยท garden-variety mole

Common acquired naevi are benign clonal proliferations of melanocytes acquired through childhood, adolescence and early adulthood. The total naevus count plateaus around age 30-40 and slowly declines from middle age. Three histological subtypes โ€” junctional, compound and intradermal โ€” represent the natural maturation continuum of a single naevus over decades. Their importance in skin oncology is twofold: (1) the strongest single melanoma risk factor is total naevus count (and naevus count is incorporated in UK pre-test melanoma risk tools); (2) they are the principal benign differential for melanoma at biopsy.

CurrentLast reviewed 16 May 2026

Natural evolution

  • Junctional naevus: flat, well-demarcated tan-brown macule; nests of melanocytes confined to the dermo-epidermal junction. Predominantly children and adolescents.
  • Compound naevus: slightly elevated; combined junctional and dermal melanocyte populations. Young adults.
  • Intradermal naevus: dome-shaped, often skin-coloured or lightly pigmented; melanocytes entirely within the dermis. Older adults.
  • Maturation: surface flatness โ†’ elevation; pigment loss; hair (terminal); fibrosis. Typical lifecycle 30-40 years.
  • Total naevus count: peaks 20-30 years; declines from 40 onwards.

Genetics and biology

  • ~80% of common naevi harbour somatic BRAF V600E mutation.
  • A minority are NRAS-mutant — NRAS is the characteristic driver of congenital naevi.
  • Single mutation followed by senescence / growth arrest underlies the small size and stability of naevi (unlike melanoma which acquires additional driver mutations).
  • Heritable factors: total naevus count is heritable; MC1R variants increase number and atypia.

Clinical and dermoscopic features

  • Symmetric in shape, colour, and structure.
  • Well-demarcated border.
  • Single dominant colour (light to medium brown typically).
  • <6 mm diameter usually; can be larger in adolescents.
  • Stable over time after age 30; concerning if new or changing in adults >40.
  • Dermoscopy: globular, reticular, homogeneous patterns; symmetric; benign network with regular meshes; centrally hyperpigmented globules.
  • Hair within naevus does not indicate atypia.

Melanoma risk

  • Total naevus count is the strongest single risk factor for melanoma:
    • >100 common naevi: relative risk ~7-fold.
    • โ‰ฅ5 atypical / dysplastic naevi: relative risk ~6-fold.
  • The risk attributable to naevus count is not eliminated by reducing the naevi themselves โ€” surveillance is the appropriate strategy.
  • UK 2-week-wait NICE NG12 weighted 7-point checklist for melanoma considers changes in pre-existing naevi.
  • Total body photography / dermoscopy with sequential imaging is NICE NG14-supported for high naevus-count / dysplastic naevus syndrome.

Red flags / when to biopsy

  • Asymmetry, Border irregularity, Colour variation, Diameter >6 mm, Evolution (ABCDE).
  • Glasgow 7-point checklist:
    • Major (2 points each): change in size, change in shape, change in colour.
    • Minor (1 point each): diameter โ‰ฅ7 mm, inflammation, oozing / crusting / bleeding, change in sensation.
    • Score โ‰ฅ3 โ†’ refer.
  • New naevus appearing in adults >40 years.
  • "Ugly duckling" โ€” a naevus that looks distinctly different from the patient's other naevi.
  • Asymmetric dermoscopic features: atypical pigment network, blue-white veil, regression structures, atypical pseudopods / streaks / dots.

Management

  • Stable, benign-appearing naevi: reassurance + skin self-examination education.
  • Suspicious naevi: full excisional biopsy with 1-2 mm margin (NICE NG14).
  • Cosmetic removal: shave excision for elevated intradermal naevi (counsel about pigment / hair regrowth).
  • Avoid laser / cryotherapy / curettage on pigmented lesions โ€” destroys diagnostic histology.
  • Surveillance for high-risk patients:
    • Naevus count >100, atypical naevus syndrome, familial melanoma, prior melanoma.
    • Annual total-body photography ยฑ sequential dermoscopy.
    • UV photoprotection counselling.
  • Counsel: lifelong surveillance; new naevus appearance in adults warrants assessment; ABCDE rule.

References

  1. Bauer J, Garbe C. Acquired melanocytic nevi as risk factor for melanoma development. Pigment Cell Res. 2003;16:297-306.
  2. Pollock PM et al. High frequency of BRAF mutations in nevi. Nat Genet. 2003;33:19-20.
  3. NICE NG14. Melanoma: assessment and management. London: NICE; 2015 (last updated 27 July 2022).
  4. NICE NG12. Suspected cancer: recognition and referral. London: NICE; 2015 (last updated 15 April 2026).
  5. Argenziano G et al. Dermoscopy of pigmented skin lesions: results of a consensus meeting. J Am Acad Dermatol. 2003;48:679-693.
  6. Gandini S et al. Meta-analysis of risk factors for cutaneous melanoma. Number of nevi. Eur J Cancer. 2005;41:28-44.

Spot a correction?

If any clinical statement, citation or link on this page needs updating, please email admin@skinoncology.net with the page name, the proposed correction and the supporting source.